Immune and Neuroendocrine Mechanisms of Stress Vulnerability and Resilience

Neuropsychopharmacology

Volumn 42, Issue 1, 2017, Pages 62-80

  Ménard, Caroline ^a   Pfau, Madeline L ^a   Hodes, Georgia E ^a   Russo, Scott J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRADYKININ; HISTAMINE; LEUKOTRIENE; PROSTAGLANDIN; SEROTONIN; CYTOKINE;

ADAPTIVE IMMUNITY; ANTIINFLAMMATORY ACTIVITY; COPING BEHAVIOR; DENDRITIC CELL; GRANULOCYTE; HUMAN; HYPERACTIVITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL MEMORY; IMMUNOMODULATION; INNATE IMMUNITY; MACROPHAGE; MAJOR DEPRESSION; MEMORY T LYMPHOCYTE; MENTAL PATIENT; MENTAL STRESS; MONOCYTE; NEUROBIOLOGY; NEUROENDOCRINOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SIGNAL TRANSDUCTION; STRESS RESILIENCE; STRESS VULNERABILITY; TREATMENT RESPONSE; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOLOGY; INFLAMMATION; METABOLISM; MICROGLIA; MOOD DISORDER;

CYTOKINES; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFLAMMATION; MICROGLIA; MONOCYTES; MOOD DISORDERS; PITUITARY-ADRENAL SYSTEM; STRESS, PSYCHOLOGICAL;

EID: 84977085541     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2016.90     Document Type: Review

References (247)

1. Ainiala H, Loukkola J, Peltola J, Korpela M, Hietaharju A (2001). The prevalence ofneuropsychiatric syndromes in systemic lupus erythematosus. Neurology 57:496-500.
2. Ajami B, Bennett JL, Krieger C, McNagny KM, Rossi FM (2011). Infiltratingmonocytes trigger EAE progression, but do not contribute to the residentmicroglia pool. Nat Neurosci 14: 1142-1149.
3. Ali S, Stone MA, Peters JL, Davies MJ, Khunti K (2006). The prevalence ofco-morbid depression in adults with type 2 diabetes: a systematic review andmeta-analysis. Diabet Med 23: 1165-1173.
4. Amateau SK, McCarthy MM (2002). Sexual differentiation of astrocyte morphology inthe developing rat preoptic area. J Neuroendocrinol 14: 904-910.
5. Amateau SK, McCarthy MM (2004). Induction of PGE2 by estradiol mediatesdevelopmental masculinization of sex behavior. Nat Neurosci 7: 643-650.
6. Amsterdam A, Tajima K, Sasson R (2002). Cell-specific regulation of apoptosis byglucocorticoids: implication to their anti-inflammatory action. Biochem Pharmacol64: 843-850.
7. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ (2001). The prevalence ofcomorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24:1069-1078.
8. Arletti R, Bertolini A (1987). Oxytocin acts as an antidepressant in two animal modelsof depression. Life Sci 41: 1725-1730.
9. Ataka K, Asakawa A, Nagaishi K, Kaimoto K, Sawada A, Hayakawa Y, et al. (2013). Bone marrow-derived microglia infiltrate into the paraventricular nucleus ofchronic psychological stress-loaded mice. PLoS One 8: e81744.
10. Avitsur R, Kavelaars A, Heijnen C, Sheridan JF (2005). Social stress and theregulation of tumor necrosis factor-alpha secretion. Brain Behav Immun 19:311-317.
11. Avitsur R, Padgett DA, Dhabhar FS, Stark JL, Kramer KA, Engler H, et al. (2003). Expression of glucocorticoid resistance following social stress requires asecond signal. J Leukoc Biol 74: 507-513.
12. Avitsur R, Stark JL, Sheridan JF (2001). Social stress induces glucocorticoidresistance in subordinate animals. Horm Behav 39: 247-257.
13. Baker DG, Ekhator NN, Kasckow JW, Hill KK, Zoumakis E, Dashevsky BA, et al. (2001). Plasma and cerebrospinal fluid interleukin-6 concentrations in posttraumaticstress disorder. Neuroimmunomodulation 9: 209-217.
14. Banks WA, Kastin AJ, Broadwell RD (1995). Passage of cytokines across the bloodbrainbarrier. Neuroimmunomodulation 2: 241-248.
15. Banks WA, Kastin AJ, Gutierrez EG (1994). Penetration of interleukin-6 across themurine blood-brain barrier. Neurosci Lett 179: 53-56.
16. Barnes PJ, Adcock IM (2009). Glucocorticoid resistance in inflammatory diseases. Lancet 373: 1905-1917.
17. Baruch K, Schwartz M (2013). CNS-specific T cells shape brain function via thechoroid plexus. Brain Behav Immun 34: 11-16.
18. Basterzi AD, Aydemir C, Kisa C, Aksaray S, Tuzer V, Yazici K, et al. (2005). IL-6 levelsdecrease with SSRI treatment in patients with major depression. HumPsychopharmacol 20: 473-476.
19. Berk M, Wadee AA, Kuschke RH, O'Neill-Kerr A (1997). Acute phase proteins inmajor depression. J Psychosom Res 43: 529-534.
20. Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ, et al. (2006). Essential role of BDNF in the mesolimbic dopamine pathway in socialdefeat stress. Science 311: 864-868.
21. Black C, Miller BJ (2015). Meta-analysis of cytokines and chemokines insuicidality: distinguishing suicidal versus nonsuicidal patients. Biol Psychiatry 78:28-37.
22. Bollinger JL, Bergeon Burns CM, Wellman CL (2016). Differential effects of stress onmicroglial cell activation in male and female medial prefrontal cortex. Brain BehavImmun 52: 88-97.
23. Bomasang-Layno E, Fadlon I, Murray AN, Himelhoch S (2015). Antidepressivetreatments for Parkinson's disease: a systematic review and meta-analysis. Parkinsonism Relat Disord 21: 833-842.
24. Brachman RA, Lehmann ML, Maric D, Herkenham M (2015). Lymphocytes fromchronically stressed mice confer antidepressant-like effects to naive mice. J Neurosci 35: 1530-1538.
25. Brevet M, Kojima H, Asakawa A, Atsuchi K, Ushikai M, Ataka K, et al. (2010). Chronicfoot-shock stress potentiates the influx of bone marrow-derived microglia intohippocampus. J Neurosci Res 88: 1890-1897.
26. Brietzke E, Scheinberg M, Lafer B (2011). Therapeutic potential of interleukin-6antagonism in bipolar disorder. Med Hypotheses 76: 21-23.
27. Brown ES, Varghese FP, McEwen BS (2004). Association of depression withmedical illness: does cortisol play a role? Biol Psychiatry 55: 1-9.
28. Charney DS (2004). Psychobiological mechanisms of resilience and vulnerability:implications for successful adaptation to extreme stress. Am J Psychiatry 161:195-216.
29. Chen E, Miller GE, Kobor MS, Cole SW (2011). Maternal warmth buffers the effectsof low early-life socioeconomic status on pro-inflammatory signaling in adulthood. Mol Psychiatry 16: 729-737.
30. Chourbaji S, Zacher C, Sanchis-Segura C, Dormann C, Vollmayr B, Gass P (2005). Learned helplessness: validity and reliability of depressive-like states in mice. BrainRes Brain Res Protoc 16: 70-78.
31. Christoffel DJ, Golden SA, Dumitriu D, Robison AJ, Janssen WG, Ahn HF, et al. (2011a). IkappaB kinase regulates social defeat stress-induced synaptic andbehavioral plasticity. J Neurosci 31: 314-321.
32. Christoffel DJ, Golden SA, Heshmati M, Graham A, Birnbaum S, Neve RL, et al. (2012). Effects of inhibitor of kappaB kinase activity in the nucleus accumbens onemotional behavior. Neuropsychopharmacology 37: 2615-2623.
33. Christoffel DJ, Golden SA, Russo SJ (2011b). Structural and synaptic plasticity instress-related disorders. Rev Neurosci 22: 535-549.
34. Christoffel DJ, Golden SA, Walsh JJ, Guise KG, Heshmati M, Friedman AK, et al. (2015). Excitatory transmission at thalamo-striatal synapses mediates susceptibilityto social stress. Nat Neurosci 18: 962-964.
35. Clodi M, Vila G, Geyeregger R, Riedl M, Stulnig TM, Struck J, et al. (2008). Oxytocinalleviates the neuroendocrine and cytokine response to bacterial endotoxin inhealthy men. Am J Physiol Endocrinol Metab 295: E686-E691.
36. Cohen H, Ziv Y, Cardon M, Kaplan Z, Matar MA, Gidron Y, et al. (2006). Maladaptationto mental stress mitigated by the adaptive immune system via depletion of naturallyoccurring regulatory CD4+CD25+ cells. J Neurobiol 66: 552-563.
37. Cohen S, Janicki-Deverts D, Doyle WJ, Miller GE, Frank E, Rabin BS, et al. (2012). Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proc Natl Acad Sci USA 109: 5995-5999.
38. Cole SW, Conti G, Arevalo JM, Ruggiero AM, Heckman JJ, Suomi SJ (2012). Transcriptional modulation of the developing immune system by early life socialadversity. Proc Natl Acad Sci USA 109: 20578-20583.
39. Conversano C, Carmassi C, Carlini M, Casu G, Gremigni P, Dell'Osso L (2015). Interferon alpha therapy in patients with chronic hepatitis c infection: quality of lifeand depression. Hematol Rep 7: 5632.
40. Cruess DG, Evans DL, Repetto MJ, Gettes D, Douglas SD, Petitto JM (2003). Prevalence, diagnosis, and pharmacological treatment of mood disorders in HIVdisease. Biol Psychiatry 54: 307-316.
41. Dalmau I, Finsen B, Zimmer J, Gonzalez B, Castellano B (1998). Development ofmicroglia in the postnatal rat hippocampus. Hippocampus 8: 458-474.
42. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW (2008). Frominflammation to sickness and depression: when the immune system subjugatesthe brain. Nat Rev Neurosci 9: 46-56.
43. Daynes RA, Araneo BA, Ershler WB, Maloney C, Li GZ, Ryu SY (1993). Alteredregulation of IL-6 production with normal aging. Possible linkage to the ageassociateddecline in dehydroepiandrosterone and its sulfated derivative. J Immunol 150: 5219-5230.
44. De Bosscher K, Vanden Berghe W, Haegeman G (2003). The interplay between theglucocorticoid receptor and nuclear factor-kappaB or activator protein-1:molecular mechanisms for gene repression. Endocr Rev 24: 488-522.
45. De Kock M, Loix S, Lavand'homme P (2013). Ketamine and peripheral inflammation. CNS Neurosci Ther 19: 403-410.
46. Dickens C, McGowan L, Clark-Carter D, Creed F (2002). Depression in rheumatoidarthritis: a systematic review of the literature with meta-analysis. Psychosom Med64: 52-60.
47. Domercq M, Brambilla L, Pilati E, Marchaland J, Volterra A, Bezzi P (2006). P2Y1receptor-evoked glutamate exocytosis from astrocytes: control by tumor necrosisfactor-alpha and prostaglandins. J Biol Chem 281: 30684-30696.
48. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. (2010). A metaanalysisof cytokines in major depression. Biol Psychiatry 67: 446-457.
49. Eller T, Vasar V, Shlik J, Maron E (2008). Pro-inflammatory cytokines and treatmentresponse to escitalopram in major depressive disorder. Prog NeuropsychopharmacolBiol Psychiatry 32: 445-450.
50. Eyre HA, Air T, Proctor S, Rositano S, Baune BT (2015). A critical review of theefficacy of non-steroidal anti-inflammatory drugs in depression. Prog NeuropsychopharmacolBiol Psychiatry 57: 11-16.
51. Fagundes CP, Glaser R, Hwang BS, Malarkey WB, Kiecolt-Glaser JK (2013). Depressive symptoms enhance stress-induced inflammatory responses. BrainBehav Immun 31: 172-176.
52. Felger JC, Haroon E, Woolwine BJ, Raison CL, Miller AH (2015a). Interferon-alphainducedinflammation is associated with reduced glucocorticoid negative feedbacksensitivity and depression in patients with hepatitis C virus. Physiol Behav. pii: S0031-9384(15)30210-9.
53. Felger JC, Li Z, Haroon E, Woolwine BJ, Jung MY, Hu X, et al. (2015b). Inflammationis associated with decreased functional connectivity within corticostriatal rewardcircuitry in depression. Mol Psychiatry (e-pub ahead of print).
54. Fenton WS, Stover ES (2006). Mood disorders: cardiovascular and diabetescomorbidity. Curr Opin Psychiatry 19: 421-427.
55. Fiedorowicz JG, Prossin AR, Johnson CP, Christensen GE, Magnotta VA,Wemmie JA (2015). Peripheral inflammation during abnormal mood states inbipolar I disorder. J Affect Disord 187: 172-178.
56. Fornaro M, Rocchi G, Escelsior A, Contini P, Martino M (2013). Might differentcytokine trends in depressed patients receiving duloxetine indicate differentialbiological backgrounds. J Affect Disord 145: 300-307.
57. Frank MG, Baratta MV, Sprunger DB, Watkins LR, Maier SF (2007). Microgliaserve as a neuroimmune substrate for stress-induced potentiation of CNSpro-inflammatory cytokine responses. Brain Behav Immun 21: 47-59.
58. Frank MG, Watkins LR, Maier SF (2013). Stress-induced glucocorticoids as aneuroendocrine alarm signal of danger. Brain Behav Immun 33: 1-6.
59. Frank MG, Weber MD, Watkins LR, Maier SF (2015). Stress sounds the alarmin: therole of the danger-associated molecular pattern HMGB1 in stress-inducedneuroinflammatory priming. Brain Behav Immun 48: 1-7.
60. Frasch A, Zetzsche T, Steiger A, Jirikowski GF (1995). Reduction of plasma oxytocinlevels in patients suffering from major depression. Adv Exp Med Biol 395:257-258.
61. Galea LA, McEwen BS, Tanapat P, Deak T, Spencer RL, Dhabhar FS (1997). Sexdifferences in dendritic atrophy of CA3 pyramidal neurons in response to chronicrestraint stress. Neuroscience 81: 689-697.
62. Garmezy N (1971). Vulnerability research and the issue of primary prevention. Am JOrthopsychiatry 41: 101-116.
63. Gill J, Vythilingam M, Page GG (2008). Low cortisol, high DHEA, and high levels ofstimulated TNF-alpha, and IL-6 in women with PTSD. J Trauma Stress 21:530-539.
64. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, et al. (2010). Fatemapping analysis reveals that adult microglia derive from primitive macrophages. Science 330: 841-845.
65. Ginhoux F, Jung S (2014). Monocytes and macrophages: developmental pathwaysand tissue homeostasis. Nat Rev Immunol 14: 392-404.
66. Golden SA, Covington HE 3rd, Berton O, Russo SJ (2011). A standardized protocolfor repeated social defeat stress in mice. Nat Protoc 6: 1183-1191.
67. Goldstein BI, Kemp DE, Soczynska JK, McIntyre RS (2009). Inflammationand the phenomenology, pathophysiology, comorbidity, and treatment ofbipolar disorder: a systematic review of the literature. J Clin Psychiatry 70:1078-1090.
68. Goldstein DS, McEwen B (2002). Allostasis, homeostats, and the nature of stress. Stress 5: 55-58.
69. Gorski RA, Gordon JH, Shryne JE, Southam AM (1978). Evidence for amorphological sex difference within the medial preoptic area of the rat brain. Brain Res 148: 333-346.
70. Grippo AJ, Francis J, Beltz TG, Felder RB, Johnson AK (2005). Neuroendocrine andcytokine profile of chronic mild stress-induced anhedonia. Physiol Behav 84:697-706.
71. Grippo AJ, Trahanas DM, Zimmerman RR 2nd, Porges SW, Carter CS (2009). Oxytocin protects against negative behavioral and autonomic consequences oflong-term social isolation. Psychoneuroendocrinology 34: 1542-1553.
72. Hamby ME, Coppola G, Ao Y, Geschwind DH, Khakh BS, Sofroniew MV (2012). Inflammatory mediators alter the astrocyte transcriptome and calciumsignaling elicited by multiple G-protein-coupled receptors. J Neurosci 32:14489-14510.
73. Hanamsagar R, Bilbo SD (2015). Sex differences in neurodevelopmental andneurodegenerative disorders: Focus on microglial function and neuroinflammationduring development. J Steroid Biochem Mol Biol 160: 127-133.
74. Harrison JK, Jiang Y, Chen S, Xia Y, Maciejewski D, McNamara RK, et al. (1998). Rolefor neuronally derived fractalkine in mediating interactions between neurons andCX3CR1-expressing microglia. Proc Natl Acad Sci USA 95: 10896-10901.
75. Heidt T, Sager HB, Courties G, Dutta P, Iwamoto Y, Zaltsman A, et al. (2014). Chronicvariable stress activates hematopoietic stem cells. Nat Med 20: 754-758.
76. Heim C, Young LJ, Newport DJ, Mletzko T, Miller AH, Nemeroff CB (2009). LowerCSF oxytocin concentrations in women with a history of childhood abuse. MolPsychiatry 14: 954-958.
77. Hellwig S, Brioschi S, Dieni S, Frings L, Masuch A, Blank T, et al. (2015). Alteredmicroglia morphology and higher resilience to stress-induced depression-likebehavior in CX3CR1-deficient mice. Brain Behav Immun 55: 126-137.
78. Hernandez ME, Mendieta D, Martinez-Fong D, Loria F, Moreno J, Estrada I, et al. (2008). Variations in circulating cytokine levels during 52 week course of treatmentwith SSRI for major depressive disorder. Eur Neuropsychopharmacol 18:917-924.
79. Hinwood M, Tynan RJ, Charnley JL, Beynon SB, Day TA, Walker FR (2013). Chronicstress induced remodeling of the prefrontal cortex: structural re-organization ofmicroglia and the inhibitory effect of minocycline. Cereb Cortex 23: 1784-1797.
80. Hodes GE (2013). Sex, stress, and epigenetics: regulation of behavior in animalmodels of mood disorders. Biol Sex Differ 4: 1.
81. Hodes GE, Kana V, Menard C, Merad M, Russo SJ (2015a). Neuroimmunemechanisms of depression. Nat Neurosci 18: 1386-1393.
82. Hodes GE, Pfau ML, Leboeuf M, Golden SA, Christoffel DJ, Bregman D, et al. (2014). Individual differences in the peripheral immune system promote resilience versussusceptibility to social stress. Proc Natl Acad Sci USA 111: 16136-16141.
83. Hodes GE, Pfau ML, Purushothaman I, Ahn HF, Golden SA, Christoffel DJ, et al. (2015b). Sex differences in nucleus accumbens transcriptome profiles associatedwith susceptibility versus resilience to subchronic variable stress. J Neurosci 35:16362-16376.
84. Hsu B, Wang D, Sun Y, Salvadore G, Singh J, Curran M, et al. (2015). Improvement inmeasures of depressed mood and anhedonia, and fatigue, in a randomized,placebo-controlled, phase 2 study of sirukumab, a human anti-interleukin-6antibody, in patients with rheumatoid arthritis. Ann Rheum Dis 74(Suppl 2):720-721.
85. Hu Q, Zhang SY, Liu F, Zhang YL, Zhu DM, Zang YY (2015). Clinical significance ofdecreased protein expression of dehydroepiandrosterone sulfate in the developmentof depression: a meta-analysis. J Affect Disord 174: 416-423.
86. Hua JY, Smith SJ (2004). Neural activity and the dynamics of central nervous systemdevelopment. Nat Neurosci 7: 327-332.
87. Huang TL, Lee CT (2007). T-helper 1/T-helper 2 cytokine imbalance and clinicalphenotypes of acute-phase major depression. Psychiatry Clin Neurosci 61:415-420.
88. Hung CC, Lin CH, Chang H, Wang CY, Lin SH, Hsu PC, et al. (2016). Astrocytic GAP43 induced by the TLR4/NF-kappaB/STAT3 axis attenuatesastrogliosis-mediated microglial activation and neurotoxicity. J Neurosci 36:2027-2043.
89. Iwata M, Ota KT, Duman RS (2013). The inflammasome: pathways linkingpsychological stress, depression, and systemic illnesses. Brain Behav Immun 31:105-114.
90. Iwata M, Ota KT, Li XY, Sakaue F, Li N, Dutheil S, et al. (2015). Psychological stressactivates the inflammasome via release of adenosine triphosphate and stimulationof the purinergic type 2X7 receptor. Biol Psychiatry 80: 12-22.
91. Iyengar RL, Gandhi S, Aneja A, Thorpe K, Razzouk L, Greenberg J, et al. (2013). NSAIDs are associated with lower depression scores in patients withosteoarthritis. Am J Med 126: 1017 e1011-1017 e1018.
92. Jazayeri S, Keshavarz SA, Tehrani-Doost M, Djalali M, Hosseini M, Amini H, et al. (2010). Effects of eicosapentaenoic acid and fluoxetine on plasma cortisol, seruminterleukin-1beta and interleukin-6 concentrations in patients with majordepressive disorder. Psychiatry Res 178: 112-115.
93. Jiang M, Qin P, Yang X (2014). Comorbidity between depression andasthma via immune-inflammatory pathways: a meta-analysis. J Affect Disord 166:22-29.
94. Kalelioglu T, Akkus M, Karamustafalioglu N, Genc A, Genc ES, Cansiz A, et al. (2015). Neutrophil-lymphocyte and platelet-lymphocyte ratios as inflammation markers forbipolar disorder. Psychiatry Res 228: 925-927.
95. Kapczinski F, Dal-Pizzol F, Teixeira AL, Magalhaes PV, Kauer-Sant'Anna M, Klamt Fet al (2011). Peripheral biomarkers and illness activity in bipolar disorder. J Psychiatr Res 45: 156-161.
96. Katz LC, Shatz CJ (1996). Synaptic activity and the construction of cortical circuits. Science 274: 1133-1138.
97. Kearns MC, Ressler KJ, Zatzick D, Rothbaum BO (2012). Early interventions forPTSD: a review. Depress Anxiety 29: 833-842.
98. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE (2005). Prevalence,severity, and comorbidity of 12-month DSM-IV disorders in the NationalComorbidity Survey Replication. Arch Gen Psychiatry 62: 617-627.
99. Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB (1993). Sex anddepression in the National Comorbidity Survey. I: lifetime prevalence, chronicityand recurrence. J Affect Disord 29: 85-96.
100. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders inthe United States. Results from the National Comorbidity Survey. Arch GenPsychiatry 51: 8-19.
101. Kessler RC, van Loo HM, Wardenaar KJ, Bossarte RM, Brenner LA, Ebert DD, et al. (2016). Using patient self-reports to study heterogeneity of treatment effects inmajor depressive disorder. Epidemiol Psychiatr Sci 1-15.
102. Kim YK, Suh IB, Kim H, Han CS, Lim CS, Choi SH, et al. (2002). The plasma levels ofinterleukin-12 in schizophrenia, major depression, and bipolar mania: effects ofpsychotropic drugs. Mol Psychiatry 7: 1107-1114.
103. Kirschbaum C, Prussner JC, Stone AA, Federenko I, Gaab J, Lintz D, et al. (1995). Persistent high cortisol responses to repeated psychological stress in asubpopulation of healthy men. Psychosom Med 57: 468-474.
104. Kitraki E, Kremmyda O, Youlatos D, Alexis MN, Kittas C (2004). Gender-dependentalterations in corticosteroid receptor status and spatial performance following21 days of restraint stress. Neuroscience 125: 47-55.
105. Kohler O, Benros ME, Nordentoft M, Farkouh ME, Iyengar RL, Mors O, et al. (2014). Effect of anti-inflammatory treatment on depression, depressive symptoms, andadverse effects: a systematic review and meta-analysis of randomizedclinical trials. JAMA Psychiatry 71: 1381-1391.
106. Koo JW, Duman RS (2008). IL-1beta is an essential mediator of the antineurogenicand anhedonic effects of stress. Proc Natl Acad Sci USA 105: 751-756.
107. Korn T, Bettelli E, Oukka M, Kuchroo VK (2009). IL-17 and Th17 Cells. Annu RevImmunol 27: 485-517.
108. Kreisel T, Frank MG, Licht T, Reshef R, Ben-Menachem-Zidon O, Baratta MV, et al. (2014). Dynamic microglial alterations underlie stress-induced depressive-likebehavior and suppressed neurogenesis. Mol Psychiatry 19: 699-709.
109. Krishnan V, Han MH, Graham DL, Berton O, Renthal W, Russo SJ, et al. (2007). Molecular adaptations underlying susceptibility and resistance to social defeat inbrain reward regions. Cell 131: 391-404.
110. Krishnan V, Nestler EJ (2008). The molecular neurobiology of depression. Nature455: 894-902.
111. Kubera M, Kenis G, Bosmans E, Kajta M, Basta-Kaim A, Scharpe S, et al. (2004). Stimulatory effect of antidepressants on the production of IL-6. Int Immunopharmacol4: 185-192.
112. Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H (2000). Cytokine productionand treatment response in major depressive disorder. Neuropsychopharmacology22: 370-379.
113. Laye S, Parnet P, Goujon E, Dantzer R (1994). Peripheral administration oflipopolysaccharide induces the expression of cytokine transcripts in the brain andpituitary of mice. Brain Res Mol Brain Res 27: 157-162.
114. Lee KM, Kim YK (2006). The role of IL-12 and TGF-beta1 in the pathophysiology ofmajor depressive disorder. Int Immunopharmacol 6: 1298-1304.
115. Lee HB, Lyketsos CG (2003). Depression in Alzheimer's disease: heterogeneity andrelated issues. Biol Psychiatry 54: 353-362.
116. Lenz KM, McCarthy MM (2015). A starring role for microglia in brain sex differences. Neuroscientist 21: 306-321.
117. Lenz KM, Nugent BM, Haliyur R, McCarthy MM (2013). Microglia are essential tomasculinization of brain and behavior. J Neurosci 33: 2761-2772.
118. Leo R, Di Lorenzo G, Tesauro M, Razzini C, Forleo GB, Chiricolo G, et al. (2006). Association between enhanced soluble CD40 ligand and proinflammatory andprothrombotic states in major depressive disorder: pilot observations on the effectsof selective serotonin reuptake inhibitor therapy. J Clin Psychiatry 67: 1760-1766.
119. Lewitus GM, Schwartz M (2009a). Behavioral immunization: immunity to selfantigenscontributes to psychological stress resilience. Mol Psychiatry 14:532-536.
120. Lewitus GM, Wilf-Yarkoni A, Ziv Y, Shabat-Simon M, Gersner R, Zangen A, et al. (2009b). Vaccination as a novel approach for treating depressive behavior. BiolPsychiatry 65: 283-288.
121. Liu HC, Yang YY, Chou YM, Chen KP, Shen WW, Leu SJ (2004). Immunologicvariables in acute mania of bipolar disorder. J Neuroimmunol 150: 116-122.
122. Lopez AD, Murray CC (1998). The global burden of disease, 1990-2020. Nat Med 4:1241-1243.
123. Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, et al. (2015). Structural and functional features of central nervous system lymphatic vessels. Nature 523: 337-341.
124. Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW, et al. (2010). Overweight, obesity, and depression: a systematic review and meta-analysis oflongitudinal studies. Arch Gen Psychiatry 67: 220-229.
125. Maes M (1995). Evidence for an immune response in major depression: a review andhypothesis. Prog Neuropsychopharmacol Biol Psychiatry 19: 11-38.
126. Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H (1997). Increased serum IL-6 and IL-1 receptor antagonist concentrations in majordepression and treatment resistant depression. Cytokine 9: 853-858.
127. Maes M, Bosmans E, Meltzer HY, Scharpe S, Suy E (1993). Interleukin-1 beta: aputative mediator of HPA axis hyperactivity in major depression? Am J Psychiatry150: 1189-1193.
128. Maes M, Kubera M, Obuchowiczwa E, Goehler L, Brzeszcz J (2011). Depression'smultiple comorbidities explained by (neuro)inflammatory and oxidative andnitrosative stress pathways. Neuro Endocrinol Lett 32: 7-24.
129. Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R, et al. (1995a). Increased plasma concentrations of interleukin-6, soluble interleukin-6,soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord34: 301-309.
130. Maes M, Van der Planken M, Stevens WJ, Peeters D, DeClerck LS, Bridts CH, et al. (1992). Leukocytosis, monocytosis and neutrophilia: hallmarks of severedepression. J Psychiatr Res 26: 125-134.
131. Maes M, Vandoolaeghe E, Ranjan R, Bosmans E, Bergmans R, Desnyder R (1995b). Increased serum interleukin-1-receptor-antagonist concentrations in majordepression. J Affect Disord 36: 29-36.
132. Maier SF (1990). Role of fear in mediating shuttle escape learning deficit produced byinescapable shock. J Exp Psychol Anim Behav Process 16: 137-149.
133. Maier SF, Watkins LR (1995). Intracerebroventricular interleukin-1 receptorantagonist blocks the enhancement of fear conditioning and interference withescape produced by inescapable shock. Brain Res 695: 279-282.
134. Marrie RA, Reingold S, Cohen J, Stuve O, Trojano M, Sorensen PS, et al. (2015). Theincidence and prevalence of psychiatric disorders in multiple sclerosis: asystematic review. Mult Scler 21: 305-317.
135. Martin LA, Neighbors HW, Griffith DM (2013). The experience of symptoms ofdepression in men vs women: analysis of the National Comorbidity SurveyReplication. JAMA Psychiatry 70: 1100-1106.
136. Mason DR, Beck PL, Muruve DA (2012). Nucleotide-binding oligomerizationdomain-like receptors and inflammasomes in the pathogenesis of non-microbialinflammation and diseases. J Innate Immun 4: 16-30.
137. Masten AS (2001). Ordinary magic. Resilience processes in development. AmPsychol 56: 227-238.
138. Matcham F, Rayner L, Steer S, Hotopf M (2014). The prevalence of depression inrheumatoid arthritis: a systematic review and meta-analysis: reply. Rheumatology(Oxford) 53: 578-579.
139. Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, et al. (2008). Anxiety and depression in COPD: current understanding, unansweredquestions, and research needs. Chest 134(4 Suppl): 43S-56S.
140. McEwen BS, Gray JD, Nasca C (2015). 60 Years of neuroendocrinology: redefiningneuroendocrinology: stress, sex and cognitive and emotional regulation. J Endocrinol 226: T67-T83.
141. McQuaid RJ, McInnis OA, Abizaid A, Anisman H (2014). Making room for oxytocin inunderstanding depression. Neurosci Biobehav Rev 45: 305-322.
142. Meeuwsen S, Persoon-Deen C, Bsibsi M, Ravid R, van Noort JM (2003). Cytokine,chemokine and growth factor gene profiling of cultured human astrocytes afterexposure to proinflammatory stimuli. Glia 43: 243-253.
143. Menard C, Hodes GE, Russo SJ (2016). Pathogenesis of depression: insights fromhuman and rodent studies. Neuroscience 321: 138-162.
144. Mikova O, Yakimova R, Bosmans E, Kenis G, Maes M (2001). Increased serumtumor necrosis factor alpha concentrations in major depression and multiplesclerosis. Eur Neuropsychopharmacol 11: 203-208.
145. Miller AH (2010). Depression and immunity: a role for T cells? Brain Behav Immun 24:1-8.
146. Miller AH, Raison CL (2015). The role of inflammation in depression: from evolutionaryimperative to modern treatment target. Nat Rev Immunol 16: 22-34.
147. Miller GE, Chen E, Sze J, Marin T, Arevalo JM, Doll R, et al. (2008). A functionalgenomic fingerprint of chronic stress in humans: blunted glucocorticoid andincreased NF-kappaB signaling. Biol Psychiatry 64: 266-272.
148. Miller GE, Rohleder N, Stetler C, Kirschbaum C (2005). Clinical depression andregulation of the inflammatory response during acute stress. Psychosom Med 67:679-687.
149. Moieni M, Irwin MR, Jevtic I, Olmstead R, Breen EC, Eisenberger NI (2015). Sexdifferences in depressive and socioemotional responses to an inflammatorychallenge: implications for sex differences in depression. Neuropsychopharmacology40: 1709-1716.
150. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B (2007). Depression,chronic diseases, and decrements in health: results from the World HealthSurveys. Lancet 370: 851-858.
151. Mueller BR, Bale TL (2008). Sex-specific programming of offspring emotionality afterstress early in pregnancy. J Neurosci 28: 9055-9065.
152. Mueller SN, Mackay LK (2016). Tissue-resident memory T cells: local specialists inimmune defence. Nat Rev Immunol 16: 79-89.
153. Munkholm K, Weikop P, Kessing LV, Vinberg M (2015). Elevated levels of IL-6 andIL-18 in manic and hypomanic states in rapid cycling bipolar disorder patients. Brain Behav Immun 43: 205-213.
154. Munzer A, Sack U, Mergl R, Schonherr J, Petersein C, Bartsch S, et al. (2013). Impactof antidepressants on cytokine production of depressed patients in vitro Toxins(Basel) 5(11): 2227-2240.
155. Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Green CE, Perez AM, et al. (2013a). Antidepressant efficacy of ketamine in treatment-resistant majordepression: a two-site randomized controlled trial. Am J Psychiatry 170:1134-1142.
156. Murrough JW, Perez AM, Pillemer S, Stern J, Parides MK, aan het Rot M, et al. (2013b). Rapid and longer-term antidepressant effects of repeated ketamineinfusions in treatment-resistant major depression. Biol Psychiatry 74: 250-256.
157. Mutlu O, Gumuslu E, Ulak G, Celikyurt IK, Kokturk S, Kir HM, et al. (2012). Effects offluoxetine, tianeptine and olanzapine on unpredictable chronic mild stressinduceddepression-like behavior in mice. Life Sci 91: 1252-1262.
158. Nanni MG, Caruso R, Mitchell AJ, Meggiolaro E, Grassi L (2015). Depression in HIVinfected patients: a review. Curr Psychiatry Rep 17: 530.
159. Nery FG, Borba EF, Hatch JP, Soares JC, Bonfa E, Neto FL (2007). Majordepressive disorder and disease activity in systemic lupus erythematosus. ComprPsychiatry 48: 14-19.
160. Newton TL, Fernandez-Botran R, Miller JJ, Burns VE (2014). Interleukin-6 andsoluble interleukin-6 receptor levels in posttraumatic stress disorder: associationswith lifetime diagnostic status and psychological context. Biol Psychol 99:150-159.
161. Nimmerjahn A, Kirchhoff F, Helmchen F (2005). Resting microglial cells are highlydynamic surveillants of brain parenchyma in vivo. Science 308: 1314-1318.
162. Norman GJ, Karelina K, Morris JS, Zhang N, Cochran M, Courtney DeVries A (2010). Social interaction prevents the development of depressive-like behaviorpost nerve injury in mice: a potential role for oxytocin. Psychosom Med 72:519-526.
163. Opacka-Juffry J, Mohiyeddini C (2012). Experience of stress in childhood negativelycorrelates with plasma oxytocin concentration in adult men. Stress 15: 1-10.
164. Owen BM, Eccleston D, Ferrier IN, Young AH (2001). Raised levels of plasmainterleukin-1beta in major and postviral depression. Acta Psychiatr Scand 103:226-228.
165. Ozsoy S, Esel E, Kula M (2009). Serum oxytocin levels in patients with depressionand the effects of gender and antidepressant treatment. Psychiatry Res 169:249-252.
166. Panenka W, Jijon H, Herx LM, Armstrong JN, Feighan D, Wei T, et al. (2001). P2X7-like receptor activation in astrocytes increases chemokine monocytechemoattractant protein-1 expression via mitogen-activated protein kinase. J Neurosci 21: 7135-7142.
167. Pang Y, Cai Z, Rhodes PG (2001). Analysis of genes differentially expressed inastrocytes stimulated with lipopolysaccharide using cDNA arrays. Brain Res 914:15-22.
168. Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P, et al. (2011). Synaptic pruning by microglia is necessary for normal brain development. Science333: 1456-1458.
169. Parker KJ, Kenna HA, Zeitzer JM, Keller J, Blasey CM, Amico JA, et al. (2010). Preliminary evidence that plasma oxytocin levels are elevated in major depression. Psychiatry Res 178: 359-362.
170. Passos IC, Vasconcelos-Moreno MP, Costa LG, Kunz M, Brietzke E, Quevedo Jet al (2015). Inflammatory markers in post-traumatic stress disorder: a systematicreview, meta-analysis, and meta-regression. Lancet Psychiatry 2: 1002-1012.
171. Pfau ML, Russo SJ (2015). Peripheral and central mechanisms of stress resilience. Neurobiol Stress 1: 66-79.
172. Plotsky PM, Meaney MJ (1993). Early, postnatal experience alters hypothalamiccorticotropin-releasing factor (CRF) mRNA, median eminence CRF content andstress-induced release in adult rats. Brain Res Mol Brain Res 18: 195-200.
173. Portou MJ, Baker D, Abraham D, Tsui J (2015). The innate immune system,toll-like receptors and dermal wound healing: a review. Vascul Pharmacol 71:31-36.
174. Powell ND, Sloan EK, Bailey MT, Arevalo JM, Miller GE, Chen E, et al. (2013). Social stress up-regulates inflammatory gene expression in the leukocytetranscriptome via beta-adrenergic induction of myelopoiesis. Proc Natl AcadSci USA 110: 16574-16579.
175. Quan N, Stern EL, Whiteside MB, Herkenham M (1999). Induction of proinflammatorycytokine mRNAs in the brain after peripheral injection of subsepticdoses of lipopolysaccharide in the rat. J Neuroimmunol 93: 72-80.
176. Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF, et al. (2013). A randomized controlled trial of the tumor necrosis factor antagonist infliximab fortreatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 70: 31-41.
177. Ransohoff RM, Brown MA (2012). Innate immunity in the central nervous system. J Clin Invest 122: 1164-1171.
178. Ransohoff RM, Tani M (1998). Do chemokines mediate leukocyte recruitment inpost-traumatic CNS inflammation? Trends Neurosci 21: 154-159.
179. Rasmusson AM, Vythilingam M, Morgan CA 3rd (2003). The neuroendocrinologyof posttraumatic stress disorder: new directions. CNS Spectr 8: 651656-665657.
180. Renault PF, Hoofnagle JH, Park Y, Mullen KD, Peters M, Jones DB, et al. (1987). Psychiatric complications of long-term interferon alfa therapy. Arch Intern Med147: 1577-1580.
181. Ridet JL, Malhotra SK, Privat A, Gage FH (1997). Reactive astrocytes: cellular andmolecular cues to biological function. Trends Neurosci 20: 570-577.
182. Rogers JT, Morganti JM, Bachstetter AD, Hudson CE, Peters MM, Grimmig BA, et al. (2011). CX3CR1 deficiency leads to impairment of hippocampal cognitive functionand synaptic plasticity. J Neurosci 31: 16241-16250.
183. Rosenblat JD, Cha DS, Mansur RB, McIntyre RS (2014). Inflamed moods: a reviewof the interactions between inflammation and mood disorders. Prog NeuropsychopharmacolBiol Psychiatry 53: 23-34.
184. Rudisch B, Nemeroff CB (2003). Epidemiology of comorbid coronary artery diseaseand depression. Biol Psychiatry 54: 227-240.
185. Russo SJ, Murrough JW, Han MH, Charney DS, Nestler EJ (2012). Neurobiology ofresilience. Nat Neurosci 15: 1475-1484.
186. Russo SJ, Nestler EJ (2013). The brain reward circuitry in mood disorders. Nat RevNeurosci 14: 609-625.
187. Sanches M, Zunta-Soares GB, Hatch JP, Soares JC (2013). Gender differences inserum cortisol levels among patients with major depressive disorder. NeuropsychatriaNeuropsychologia 8: 89-93.
188. Sasayama D, Hattori K, Teraishi T, Hori H, Ota M, Yoshida S, et al. (2012). Negativecorrelation between cerebrospinal fluid oxytocin levels and negative symptoms ofmale patients with schizophrenia. Schizophr Res 139: 201-206.
189. Scantamburlo G, Hansenne M, Fuchs S, Pitchot W, Marechal P, Pequeux C, et al. (2007). Plasma oxytocin levels and anxiety in patients with major depression. Psychoneuroendocrinology 32: 407-410.
190. Schelling G, Roozendaal B, Krauseneck T, Schmoelz M, DE Quervain D, Briegel J(2006). Efficacy of hydrocortisone in preventing posttraumatic stress disorderfollowing critical illness and major surgery. Ann N Y Acad Sci 1071: 46-53.
191. Schwartz JM, Sholar PW, Bilbo SD (2012). Sex differences in microglial colonizationof the developing rat brain. J Neurochem 120: 948-963.
192. Seligman F, Nemeroff CB (2015). The interface of depression and cardiovasculardisease: therapeutic implications. Ann N Y Acad Sci 1345: 25-35.
193. Shechter R, London A, Schwartz M (2013). Orchestrated leukocyte recruitment toimmune-privileged sites: absolute barriers versus educational gates. Nat RevImmunol 13: 206-218.
194. Shi C, Pamer EG. (2011). Monocyte recruitment during infection and inflammation. Nat Rev Immunol 11: 762-774.
195. Sica A, Wang JM, Colotta F, Dejana E, Mantovani A, Oppenheim JJ, et al. (1990). Monocyte chemotactic and activating factor gene expression inducedin endothelial cells by IL-1 and tumor necrosis factor. J Immunol 144:3034-3038.
196. Siegert RJ, Abernethy DA (2005). Depression in multiple sclerosis: a review. J NeurolNeurosurg Psychiatry 76: 469-475.
197. Simon NM, McNamara K, Chow CW, Maser RS, Papakostas GI, Pollack MH, et al. (2008). A detailed examination of cytokine abnormalities in major depressivedisorder. Eur Neuropsychopharmacol 18: 230-233.
198. Slattery DA, Cryan JF (2014). The ups and downs of modelling mood disorders inrodents. ILAR J 55: 297-309.
199. Sluzewska A, Rybakowski J, Bosmans E, Sobieska M, Berghmans R, Maes M, et al. (1996). Indicators of immune activation in major depression. Psychiatry Res 64:161-167.
200. Sluzewska A, Rybakowski JK, Laciak M, Mackiewicz A, Sobieska M, Wiktorowicz K(1995). Interleukin-6 serum levels in depressed patients before and after treatmentwith fluoxetine. Ann N Y Acad Sci 762: 474-476.
201. Smith RS (1991). The macrophage theory of depression. Med Hypotheses 35:298-306.
202. Sofroniew MV (2009). Molecular dissection of reactive astrogliosis and glial scarformation. Trends Neurosci 32: 638-647.
203. Sofroniew MV (2014). Multiple roles for astrocytes as effectors of cytokines andinflammatory mediators. Neuroscientist 20: 160-172.
204. Stark JL, Avitsur R, Padgett DA, Campbell KA, Beck FM, Sheridan JF (2001). Socialstress induces glucocorticoid resistance in macrophages. Am J Physiol RegulIntegr Comp Physiol 280: R1799-R1805.
205. Stetler C, Miller GE (2011). Depression and hypothalamic-pituitary-adrenal activation:a quantitative summary of four decades of research. Psychosom Med 73:114-126.
206. Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, et al. (2007). The classical complement cascade mediates CNS synapse elimination. Cell 131: 1164-1178.
207. Straub RH, Buttgereit F, Cutolo M (2011). Alterations of the hypothalamic-pituitaryadrenalaxis in systemic immune diseases-a role for misguided energy regulation. Clin Exp Rheumatol 29(Suppl 68): S23-S31.
208. Straub RH, Konecna L, Hrach S, Rothe G, Kreutz M, Scholmerich J, et al. (1998). Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negativelycorrelated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion frommononuclear cells in man in vitro: possible link between endocrinosenescenceand immunosenescence. J Clin Endocrinol Metab 83: 2012-2017.
209. Stunkard AJ, Faith MS, Allison KC (2003). Depression and obesity. Biol Psychiatry54: 330-337.
210. Su SC, Sun MT, Wen MJ, Lin CJ, Chen YC, Hung YJ (2011). Brain-derivedneurotrophic factor, adiponectin, and proinflammatory markers in varioussubtypes of depression in young men. Int J Psychiatry Med 42: 211-226.
211. Suarez EC, Sundy JS, Erkanli A (2015). Depressogenic vulnerability and genderspecificpatterns of neuro-immune dysregulation: What the ratio of cortisol toC-reactive protein can tell us about loss of normal regulatory control. Brain BehavImmun 44: 137-147.
212. Suris A, North C, Adinoff B, Powell CM, Greene R (2010). Effects of exogenousglucocorticoid on combat-related PTSD symptoms. Ann Clin Psychiatry 22:274-279.
213. Sutcigil L, Oktenli C, Musabak U, Bozkurt A, Cansever A, Uzun O, et al. (2007). Pro-and anti-inflammatory cytokine balance in major depression: effect ofsertraline therapy. Clin Dev Immunol 2007: 76396.
214. Taylor MK, Padilla GA, Stanfill KE, Markham AE, Khosravi JY, Ward MD, et al. (2012). Effects of dehydroepiandrosterone supplementation during stressfulmilitary training: a randomized, controlled, double-blind field study. Stress 15:85-96.
215. Torres-Platas SG, Cruceanu C, Chen GG, Turecki G, Mechawar N (2014). Evidencefor increased microglial priming and macrophage recruitment in the dorsal anteriorcingulate white matter of depressed suicides. Brain Behav Immun 42: 50-59.
216. Traki L, Rostom S, Tahiri L, Bahiri R, Harzy T, Abouqal R, et al. (2014). Responsiveness of the EuroQol EQ-5D and Hospital Anxiety and DepressionScale (HADS) in rheumatoid arthritis patients receiving tocilizumab. ClinRheumatol 33: 1055-1060.
217. Tremblay ME, Lowery RL, Majewska AK (2010). Microglial interactions withsynapses are modulated by visual experience. PLoS Biol 8: e1000527.
218. Tremblay ME, Stevens B, Sierra A, Wake H, Bessis A, Nimmerjahn A (2011). The roleof microglia in the healthy brain. J Neurosci 31: 16064-16069.
219. Tsai SY, Chen KP, Yang YY, Chen CC, Lee JC, Singh VK, et al. (1999). Activation ofindices of cell-mediated immunity in bipolar mania. Biol Psychiatry 45: 989-994.
220. Tsai SY, Chung KH, Wu JY, Kuo CJ, Lee HC, Huang SH (2012). Inflammatorymarkers and their relationships with leptin and insulin from acute mania to fullremission in bipolar disorder. J Affect Disord 136: 110-116.
221. Tsai SY, Lee HC, Chen CC, Lee CH (2003). Plasma levels of soluble transferrinreceptors and Clara cell protein (CC16) during bipolar mania and subsequentremission. J Psychiatr Res 37: 229-235.
222. Tsai SY, Yang YY, Kuo CJ, Chen CC, Leu SJ (2001). Effects of symptomatic severityon elevation of plasma soluble interleukin-2 receptor in bipolar mania. J AffectDisord 64: 185-193.
223. Tynan RJ, Naicker S, Hinwood M, Nalivaiko E, Buller KM, Pow DV, et al. (2010). Chronic stress alters the density and morphology of microglia in a subset ofstress-responsive brain regions. Brain Behav Immun 24: 1058-1068.
224. Tynan RJ, Weidenhofer J, Hinwood M, Cairns MJ, Day TA, Walker FR (2012). Acomparative examination of the anti-inflammatory effects of SSRI and SNRIantidepressants on LPS stimulated microglia. Brain Behav Immun 26: 469-479.
225. Ulrich-Lai YM, Herman JP (2009). Neural regulation of endocrine and autonomicstress responses. Nat Rev Neurosci 10: 397-409.
226. Uyanik V, Tuglu C, Gorgulu Y, Kunduracilar H, Uyanik MS (2015). Assessment ofcytokine levels and hs-CRP in bipolar I disorder before and after treatment. Psychiatry Res 228: 386-392.
227. van Dam AM, Brouns M, Louisse S, Berkenbosch F (1992). Appearance ofinterleukin-1 in macrophages and in ramified microglia in the brain of endotoxintreatedrats: a pathway for the induction of non-specific symptoms of sickness?Brain Res 588: 291-296.
228. Veazey C, Aki SO, Cook KF, Lai EC, Kunik ME (2005). Prevalence and treatmentof depression in Parkinson's disease. J Neuropsychiatry Clin Neurosci 17:310-323.
229. Verma S, Nakaoke R, Dohgu S, Banks WA (2006). Release of cytokines by brainendothelial cells: a polarized response to lipopolysaccharide. Brain Behav Immun20: 449-455.
230. Vogelzangs N, Duivis HE, Beekman AT, Kluft C, Neuteboom J, Hoogendijk W, et al. (2012). Association of depressive disorderrs, depression characteristics andantidepressant medication with inflammation. Transl Psychiatry 2: e79.
231. Wang P, Yang HP, Tian S, Wang L, Wang SC, Zhang F, et al. (2015a). Oxytocinsecretingsystem: A major part of the neuroendocrine center regulatingimmunologic activity. J Neuroimmunol 289: 152-161.
232. Wang S, Blazer DG (2015b). Depression and cognition in the elderly. Annu Rev ClinPsychol 11: 331-360.
233. Warner-Schmidt JL, Vanover KE, Chen EY, Marshall JJ, Greengard P (2011). Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) areattenuated by antiinflammatory drugs in mice and humans. Proc Natl Acad SciUSA 108: 9262-9267.
234. Weaver IC, Champagne FA, Brown SE, Dymov S, Sharma S, Meaney MJ, et al. (2005). Reversal of maternal programming of stress responses in adult offspringthrough methyl supplementation: altering epigenetic marking later in life. J Neurosci 25: 11045-11054.
235. Weiss JM, Nath A, Major EO, Berman JW (1999). HIV-1 Tat induces monocytechemoattractant protein-1-mediated monocyte transmigration across a model ofthe human blood-brain barrier and up-regulates CCR5 expression on humanmonocytes. J Immunol 163: 2953-2959.
236. Wetzel HH, Gehl CR, Dellefave-Castillo L, Schiffman JF, Shannon KM, Paulsen JS,Huntington Study Group (2011). Suicidal ideation in Huntington disease: the roleof comorbidity. Psychiatry Res 188: 372-376.
237. Willrich MA, Murray DL, Snyder MR (2015). Tumor necrosis factor inhibitors: clinicalutility in autoimmune diseases. Transl Res 165: 270-282.
238. Wohleb ES, Hanke ML, Corona AW, Powell ND, Stiner LM, Bailey MT, et al. (2011). Beta-adrenergic receptor antagonism prevents anxiety-like behaviorand microglial reactivity induced by repeated social defeat. J Neurosci 31:6277-6288.
239. Wohleb ES, Powell ND, Godbout JP, Sheridan JF (2013). Stress-inducedrecruitment of bone marrow-derived monocytes to the brain promotes anxietylikebehavior. J Neurosci 33: 13820-13833.
240. Wright CL, McCarthy MM (2009). Prostaglandin E2-induced masculinization ofbrain and behavior requires protein kinase A, AMPA/kainate, and metabotropicglutamate receptor signaling. J Neurosci 29: 13274-13282.
241. Yamasaki R, Lu H, Butovsky O, Ohno N, Rietsch AM, Cialic R, et al. (2014). Differentialroles of microglia and monocytes in the inflamed central nervous system. J ExpMed 211: 1533-1549.
242. Yang C, Shirayama Y, Zhang JC, Ren Q, Hashimoto K (2015). Peripheral interleukin-6promotes resilience versus susceptibility to inescapable electric stress. ActaNeuropsychiatr 27: 312-316.
243. Yehuda R, Brand SR, Golier JA, Yang RK (2006). Clinical correlates of DHEAassociated with post-traumatic stress disorder. Acta Psychiatr Scand 114:187-193.
244. Yuen KW, Garner JP, Carson DS, Keller J, Lembke A, Hyde SA, et al. (2014). Plasmaoxytocin concentrations are lower in depressed vs healthy control women and areindependent of cortisol. J Psychiatr Res 51: 30-36.
245. Zhang D, Hu X, Qian L, O'Callaghan JP, Hong JS (2010). Astrogliosis in CNSpathologies: is there a role for microglia? Mol Neurobiol 41: 232-241.
246. Zhao QF, Tan L, Wang HF, Jiang T, Tan MS, Tan L, et al. (2016). The prevalence ofneuropsychiatric symptoms in Alzheimer's disease: systematic review and metaanalysis. J Affect Disord 190: 264-271.
247. Zheng X, Ma S, Kang A, Wu M, Wang L, Wang Q, et al. (2016). Chemical dampeningof Ly6C(hi) monocytes in the periphery produces anti-depressant effects in mice. Sci Rep 6: 19406.